Clinical Trials on Visual Field Defect, Central Scotoma of Both Eyes in Singapore
Total 0 results
Nothing found
Sponsors and Collaborators
- MEDA PHARMA SPA, a Viatris company
- University of Calabar Teaching Hospital
- CAR-T (Shanghai) Cell Biotechnology Co., Ltd.
- Sonal Foundation, India
- American University of Sharfah
- University of the French West Indies and French Guiana
- Susana Ferrandis Martinez
- United Cerebral Palsy-Central Arizona
- Kroken Nursing Home, Tromsø
- Istituto Di Ricerche Farmacologiche Mario Negri
- Center for Interdisciplinary Applied Research in Health, Health School of the Setubal, Polytechnic Institute
- Bank of Cyprus Oncology Center BOCOC
- Centro Studi Psicoterapia Neo-Funzionale
- UZA
- Liling Hospital of Traditional Chinese Medicine
- Contego Medical, Inc.
- Institut des Neurosciences de Montpellier
- Stepping Hill Hospital
- Bateman Horne Center
- Ege University Medical School
- View Full List
Medical Conditions
- Vascular Function; Platelet Aggregation
- Tetralogy of Fallot (TOF)
- Cardiac Performance
- Portal Vein, Cavernous Transformation of
- Fracture of Proximal Femur
- Fabry Disease, Cardiac Variant
- Forearm Fractures
- Various: Health Insurance Members That Could Benefit From Being Connected to a Specialist, e.g., Orthopedic Doctor to Treat Back Pain
- Protrusion of Lumbar Intervertebral Disc
- Chronic Female Pelvic Pain Syndrome (Disorder)
- Left Ventrucular Assist Device
- VHL-Associated Clear Cell Renal Cell Carcinoma
- Islets of Langerhans Transplantation
- Lungtransplantation
- Adult Polycystic Kidney Disease
- Ovary Injury
- Hearing Loss, Mixed
- Length of NICU Stay
- Periacetabular Osteotomy
- Focus of Study: Higher Cognition and the Vestibular System
- View Full List
Drug Interventions
- TAP-144-SR(6M)
- CEUS or Contrast enhanced Ultrasound
- Ortho Cyclen
- Fluticasone
- Toripalimab
- Supraclavicular Brachial Plexus Block with Dexmedetomidine
- 13C-GSK1322322 stable isotope powder
- CA125 guided strategy
- Polypharmacy using FDA-approved products
- Etoposide
- NOAC
- GDC-0853
- PLX3397
- Acalabrutinib
- Flibanserin
- ALN-KHK
- Idarubicin
- Combined PIPAC / IV chemotherapy treatment
- Ropivacaine 0.25%, 0.5 ml/kg
- Levetiracetam
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Austria
- Contract Research Organizations in Belgium
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Japan
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Morocco
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Poland
- Contract Research Organizations in Suriname
- Contract Research Organizations in Togo
- Contract Research Organizations in United Kingdom
- CRO list by country